Source:http://linkedlifedata.com/resource/pubmed/id/16199546
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2005-10-3
|
pubmed:databankReference | |
pubmed:abstractText |
BRCA1 and BRCA2 are the two major genes responsible for the breast and ovarian cancers that cluster in families with a genetically determined predisposition. However, regardless of the mutation detection method employed, the percentage of families without identifiable alterations of these genes exceeds 50%, even when applying stringent criteria for family selection. A small but significant increase in mutation detection rate has resulted from the discovery of large genomic alterations in BRCA1. A few studies have addressed the question of whether BRCA2 might be inactivated by the same kinds of alteration, but most were either done on a relatively small number of samples or employed cumbersome mutation detection methods of variable sensitivity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1468-6244
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e64
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16199546-BRCA2 Protein,
pubmed-meshheading:16199546-Breast Neoplasms,
pubmed-meshheading:16199546-Cloning, Molecular,
pubmed-meshheading:16199546-DNA Mutational Analysis,
pubmed-meshheading:16199546-Exons,
pubmed-meshheading:16199546-Female,
pubmed-meshheading:16199546-Gene Deletion,
pubmed-meshheading:16199546-Genetic Predisposition to Disease,
pubmed-meshheading:16199546-Genetic Testing,
pubmed-meshheading:16199546-Genome,
pubmed-meshheading:16199546-Humans,
pubmed-meshheading:16199546-Models, Genetic,
pubmed-meshheading:16199546-Molecular Sequence Data,
pubmed-meshheading:16199546-Recombination, Genetic
|
pubmed:year |
2005
|
pubmed:articleTitle |
Large genomic deletions inactivate the BRCA2 gene in breast cancer families.
|
pubmed:affiliation |
Department of Oncology and Surgical Sciences, Oncology Section, Padua, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|